Skip to main content

Table 1 Characteristics of patients and donors

From: Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China

Characteristic HLA-matched HSCT Haploidentical HSCT P
(n = 35) (n = 47)
Age, years, median (range) 35(5–52) 35(8–50) 0.679
Males/females, n 22/13 24/23 0.287
WBC count at diagnose × 109, median (range) 45.0(1.4–199.2) 36.3 (1.6–274.4) 0.147
CNS involvement    
Yes/no 3/32 6/41 0.548
Disease status at transplantation    
CR1 26 37 0.584
>CR1 9 10  
BCR-ABL at transplantation    
Negative/positive 28/7 37/10 0.888
Average mos. from diagnosis to transplant (range) 9.0(3–47) 7.0(2–19) 0.104
Cycles of prior chemotherapy (range) 5.3(2–22) 4.6(2–13) 0.411
ABO match, no. (%)    0.224
Matched 12 27  
Minor mismatched 8 7  
Major mismatched 11 9  
Major and minor mismatched 4 4  
Donor-recipient sex match    0.323
Male-male 10 16  
Male-female 9 18  
Female-male 12 8  
Female-female 4 5